by improving convenience and thereby adherence, for example via less frequent dosing, it may be possible not only to enhance glycaemic control but to improve quality of life [26, 27] and long-term health outcomes such as mortality [25] and to reduce healthcare costs [28]
Emerging research suggests GLP-1 receptor agonists may reduce inflammatory markers such as C-reactive protein and pro-inflammatory cytokines, though dedicated clinical trials examining low-dose regimens specifically for inflammation are lacking
6 Semaglutide produced significantly greater weight loss (an 1112 kg difference versus placebo) and larger improvements in pain (Western Ontario and McMaster Universities Arthritis Index [WOMAC] score: 41.7 versus 27.5)
According to the National Institute on Drug Abuse (NIDA), persistent cravings are a hallmark of substance use disorder and indicate a growing dependence on the medication
Chemical structures of some pantothenic acid derivatives The figure shows the chemical structures of the pantothenic acid derivatives: pantothenol (panthenol), calcium pantothenate, and pantethine
